171 related articles for article (PubMed ID: 32228249)
1. Polymorphism rs368234815 of interferon-λ4 gene and generation of antibodies to hepatitis B virus surface antigen in extracorporeal dialysis patients.
Grzegorzewska AE; Świderska MK; Marcinkowski W; Mostowska A; Jagodziński PP
Expert Rev Vaccines; 2020 Mar; 19(3):293-303. PubMed ID: 32228249
[No Abstract] [Full Text] [Related]
2. Polymorphism rs368234815 of interferon lambda 4 gene and spontaneous clearance of hepatitis C virus in haemodialysis patients: a case-control study.
Grzegorzewska AE; Mostowska A; Świderska MK; Marcinkowski W; Stolarek I; Figlerowicz M; Jagodziński PP
BMC Infect Dis; 2021 Jan; 21(1):102. PubMed ID: 33482747
[TBL] [Abstract][Full Text] [Related]
3. Association of the interleukin-12 polymorphic variants with the development of antibodies to surface antigen of hepatitis B virus in hemodialysis patients in response to vaccination or infection.
Grzegorzewska AE; Wobszal PM; Sowińska A; Mostowska A; Jagodziński PP
Mol Biol Rep; 2013 Dec; 40(12):6899-911. PubMed ID: 24158609
[TBL] [Abstract][Full Text] [Related]
4. Circulating Interferon-
Grzegorzewska AE; Świderska MK; Mostowska A; Jagodziński PP
Biomed Res Int; 2017; 2017():3713025. PubMed ID: 29226133
[TBL] [Abstract][Full Text] [Related]
5. Antibodies to HBV surface antigen in relation to interferon-λ3 in hemodialysis patients.
Grzegorzewska AE; Świderska MK; Mostowska A; Warchoł W; Jagodziński PP
Vaccine; 2016 Sep; 34(41):4866-4874. PubMed ID: 27595449
[TBL] [Abstract][Full Text] [Related]
6. Circulating interferon-λ3 and post-vaccination antibodies against the surface antigen of hepatitis B virus in hemodialysis patients exposed to hepatitis E virus.
Grzegorzewska AE; Świderska MK; Winnicka H; Niepolski L; Bura M; Łagiedo-Żelazowska M; Jagodziński PP
Cytokine; 2019 Nov; 123():154766. PubMed ID: 31279176
[TBL] [Abstract][Full Text] [Related]
7. IFNL4 rs368234815 and rs117648444 variants predict off-treatment HBsAg seroclearance in IFN-treated HBeAg-negative chronic hepatitis B patients.
Galmozzi E; Facchetti F; Grossi G; Loglio A; Viganò M; Lunghi G; Colombo M; Lampertico P
Liver Int; 2018 Mar; 38(3):417-423. PubMed ID: 28732143
[TBL] [Abstract][Full Text] [Related]
8. Effects of vaccine-acquired polyclonal anti-HBs antibodies on the prevention of HBV infection of non-vaccine genotypes.
Kato M; Hamada-Tsutsumi S; Okuse C; Sakai A; Matsumoto N; Sato M; Sato T; Arito M; Omoteyama K; Suematsu N; Okamoto K; Kato T; Itoh F; Sumazaki R; Tanaka Y; Yotsuyanagi H; Kato T; Kurokawa MS
J Gastroenterol; 2017 Sep; 52(9):1051-1063. PubMed ID: 28197802
[TBL] [Abstract][Full Text] [Related]
9. IL4R and IL13 polymorphic variants and development of antibodies to surface antigen of hepatitis B virus in hemodialysis patients in response to HBV vaccination or infection.
Grzegorzewska AE; Pajzderski D; Sowińska A; Mostowska A; Jagodziński PP
Vaccine; 2013 Apr; 31(14):1766-70. PubMed ID: 23462527
[TBL] [Abstract][Full Text] [Related]
10. Persistence of protection to hepatitis B vaccine and response to booster dose among children and adolescents in Dakahleya- Egypt.
Salama II; Sami SM; Salama SI; Foud WA; Abdel Hamid AT; Said ZN
Egypt J Immunol; 2014; 21(1):13-26. PubMed ID: 25204041
[TBL] [Abstract][Full Text] [Related]
11. Effect of interferon λ3 gene polymorphisms, rs8099917 and rs12979860, on response to hepatitis B virus vaccination and hepatitis B or C virus infections among hemodialysis patients.
Grzegorzewska AE; Jodłowska E; Mostowska A; Jagodziński P
Pol Arch Med Wewn; 2015; 125(12):894-902. PubMed ID: 26658164
[TBL] [Abstract][Full Text] [Related]
12. High hepatitis B virus surface antigen levels and favorable interleukin 28B genotype predict spontaneous hepatitis C virus clearance in uremic patients.
Yu ML; Dai CY; Huang CF; Lee JJ; Yeh ML; Yeh SM; Kuo HT; Huang JF; Chang JM; Chen HC; Juo SH; Hwang SJ; Chuang WL;
J Hepatol; 2014 Feb; 60(2):253-9. PubMed ID: 24096049
[TBL] [Abstract][Full Text] [Related]
13. Paraoxonase 1 gene (PON1) variants concerning hepatitis C virus (HCV) spontaneous clearance in hemodialysis individuals: a case-control study.
Grzegorzewska AE; Mostowska A; Warchoł W; Jagodziński PP
BMC Infect Dis; 2021 Aug; 21(1):875. PubMed ID: 34445971
[TBL] [Abstract][Full Text] [Related]
14. Status of hepatitis B infection - a decade after hepatitis B vaccination of susceptible Nicobarese, an indigenous tribe of Andaman & Nicobar (A&N) islands with high hepatitis B endemicity.
Bhattacharya H; Bhattacharya D; Ghosal SR; Roy S; Sugunan AP
Indian J Med Res; 2015 May; 141(5):653-61. PubMed ID: 26139785
[TBL] [Abstract][Full Text] [Related]
15. Correlations of indoleamine 2,3-dioxygenase, interferon-λ3, and anti-HBs antibodies in hemodialysis patients.
Grzegorzewska AE; Winnicka H; Warchoł W; Mostowska A; Jagodziński PP
Vaccine; 2018 Jul; 36(30):4454-4461. PubMed ID: 29935858
[TBL] [Abstract][Full Text] [Related]
16. Relative indoleamine 2,3-dioxygenase transcript level concerning anti-HBs titers in response to HBV vaccination in hemodialysis patients.
Grzegorzewska AE; Frycz BA; Winnicka H; Warchoł W; Jagodziński PP
Expert Rev Vaccines; 2018 Oct; 17(10):947-953. PubMed ID: 30251561
[TBL] [Abstract][Full Text] [Related]
17. The hepatitis B vaccine protects re-exposed health care workers, but does not provide sterilizing immunity.
Werner JM; Abdalla A; Gara N; Ghany MG; Rehermann B
Gastroenterology; 2013 Nov; 145(5):1026-34. PubMed ID: 23916846
[TBL] [Abstract][Full Text] [Related]
18. Expression and detection of anti-HBs antibodies after hepatitis B virus infection or vaccination in the context of protective immunity.
Pondé RAA
Arch Virol; 2019 Nov; 164(11):2645-2658. PubMed ID: 31399876
[TBL] [Abstract][Full Text] [Related]
19. Efficient haemodialysis improves the response to hepatitis B virus vaccination.
Kovacic V; Sain M; Vukman V
Intervirology; 2002; 45(3):172-6. PubMed ID: 12403922
[TBL] [Abstract][Full Text] [Related]
20. Post-vaccination serologic testing of infants born to hepatitis B surface antigen positive mothers in 4 provinces of China.
Wang F; Zhang G; Zheng H; Miao N; Shen L; Wang F; Dong P; Du F; Chen C; Zhang X; Cui F
Vaccine; 2017 Jul; 35(33):4229-4235. PubMed ID: 28651839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]